These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9664909)

  • 21. Expression of the cholecystokinin 2-receptor in normal human thyroid gland and medullary thyroid carcinoma.
    Blaker M; de Weerth A; Tometten M; Schulz M; Höppner W; Arlt D; Hoang-Vu C; Dralle H; Terpe H; Jonas L; von Schrenck T
    Eur J Endocrinol; 2002 Jan; 146(1):89-96. PubMed ID: 11751073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sporadic medullary thyroid cancer.
    Harvey A; Pasieka JL
    Cancer Treat Res; 2010; 153():57-74. PubMed ID: 19957219
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thyroid paraganglioma: report of a case].
    Chen Q; Fu YB; Li BZ
    Zhonghua Bing Li Xue Za Zhi; 2011 Jul; 40(7):491-2. PubMed ID: 22088382
    [No Abstract]   [Full Text] [Related]  

  • 24. Sporadic versus familial medullary thyroid microcarcinoma.
    Harach HR
    Am J Surg Pathol; 2003 Jan; 27(1):136; author reply 136-7. PubMed ID: 12502937
    [No Abstract]   [Full Text] [Related]  

  • 25. [Malignant melanoma of the back metastatic to thyroid gland: report of a case].
    Fu CL; Zhang XT; Zhang JN
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):121-2. PubMed ID: 21426814
    [No Abstract]   [Full Text] [Related]  

  • 26. [Histological and immunohistochemical profile of sporadic and familial medullary thyroid carcinoma].
    Ríos A; Rodríguez JM; Febrero B; Acosta Ortega JM; Torregrosa N; Balsalobre M; Parrilla P
    Endocrinol Nutr; 2011 Dec; 58(10):521-8. PubMed ID: 22047736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunoexpression of multidrug-resistance protein 2 and cyclooxygenase 2 in medullary thyroid carcinomas.
    Ruggeri RM; Sciacchitano S; Vitarelli E; Trimarchi F; Barresi G; Trovato M
    Arch Pathol Lab Med; 2006 Jul; 130(7):1014-9. PubMed ID: 16831027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-cells for differentiation between familial and sporadic medullary thyroid carcinoma.
    Emmertsen K; Ernø H; Henriques U; Schrøder HD
    Dan Med Bull; 1983 Sep; 30(5):353-6. PubMed ID: 6628000
    [No Abstract]   [Full Text] [Related]  

  • 29. Expression of p8 protein in medullary thyroid carcinoma.
    Ito Y; Yoshida H; Motoo Y; Iovanna JL; Tomoda C; Uruno T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Miyauchi A
    Anticancer Res; 2005; 25(5):3419-23. PubMed ID: 16101158
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of laminin-2 by normal and neoplastic rat C cells during the development of medullary thyroid carcinoma.
    Lekmine F; Feracci H; Milhaud G; Treilhou-Lahille F; Jeanne N
    Virchows Arch; 1999 Apr; 434(4):325-32. PubMed ID: 10335943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genes involved in the metastatic cascade of medullary thyroid tumours.
    Schreiber C; Vormbrock K; Ziebold U
    Methods Mol Biol; 2012; 878():217-28. PubMed ID: 22674136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of atrial natriuretic peptide in rat thyroid medullary carcinoma cell line.
    Maekawa T; Fukui H; Okada A; Kinoshita Y; Ono Y; Fujimori T; Chiba T
    Acta Oncol; 1998; 37(5):500-2. PubMed ID: 9831383
    [No Abstract]   [Full Text] [Related]  

  • 33. Melanin production in black medullary thyroid carcinoma (MTC).
    Beerman H; Rigaud C; Bogomoletz WV; Hollander H; Veldhuizen RW
    Histopathology; 1990 Mar; 16(3):227-33. PubMed ID: 2332208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ESR2 Gene and Medullary Thyroid Carcinoma.
    Ruiz-Ferrer M; Fernández RM; Navarro E; Antiñolo G; Borrego S
    Thyroid; 2017 Nov; 27(11):1456-1457. PubMed ID: 28891392
    [No Abstract]   [Full Text] [Related]  

  • 35. [Significance of NAD (P) H: quinone oxidoreductase 1 overexpression in prognostic evaluation of thyroid medullary carcinoma].
    Jin Z; Cui X; Zhang Y; Yang Y; Li L; Lin Z; Chen L
    Zhonghua Bing Li Xue Za Zhi; 2015 Feb; 44(2):128-9. PubMed ID: 25916645
    [No Abstract]   [Full Text] [Related]  

  • 36. Protein histochemistry methods for colloid identification to metastases of thyroid carcinoma.
    Fakan F
    Neoplasma; 1976; 23(2):191-6. PubMed ID: 59319
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased incidence of medullary carcinoma of the thyroid in rural regions in Greece.
    Alevizaki M; Papapetrou P; Georgouli P; Alevizaki CC; Papadodima H; Souvatzoglou A; Koutras D
    J Endocrinol Invest; 1995 Mar; 18(3):220-3. PubMed ID: 7615908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does the syndrome of familial medullary thyroid carcinoma describe a distinct clinical entity?
    Takami H; Thosen T; Shirahama S; Ogura K; Hikiji K
    Eur J Cancer; 1998 Sep; 34(10):1639-40. PubMed ID: 9893644
    [No Abstract]   [Full Text] [Related]  

  • 39. [Familial medullary carcinoma of the thyroid].
    Pato Castel I
    Med Clin (Barc); 1984 Jan; 82(2):68-70. PubMed ID: 6708613
    [No Abstract]   [Full Text] [Related]  

  • 40. [Familial medullary carcinoma of the thyroid].
    Angel M; Vilardell E; Cabrer J
    Med Clin (Barc); 1984 Sep; 83(8):353. PubMed ID: 6521557
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.